January 10, 2003 (The Chicago Sun-Times) - An experimental clot-busting drug that someday might limit damage from strokes is derived from a most unusual source-- vampire bats. The drug might lengthen the three-hour treatment window that limits the effectiveness of the only approved drug in use, according to a study published today in Stroke: Journal of the American Heart Association.

October 10, 1996 (Peter Gilstrap / Phoenix New Times) - It takes a certain brand of optimism and foresight to make a small-market concept work, a certain drive and, of course, the essential ability to recognize a need and fill it. Before a savvy, upward mover even begins to address such concepts as outsourcing, retrenchment and severe lower-pricing to shed high-cost capacity, he must be able to pick the right product at the right moment. Such a man is Rod Jakubik. His product is fangs.